Who has invested in TISSIUM?

Cathay Health, Cathay Capital, Sofinnova Partners are named among the investors backing TISSIUM.

TISSIUM Funding: $161M Raised, Series C (2021)

TISSIUM funding overview

TISSIUM is based in Boston, Massachusetts. TISSIUM has raised $161M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in August 2021. The round record for TISSIUM runs through 2021; nothing later has been disclosed. Investors on record include Cathay Health, Cathay Capital, Sofinnova Partners. 3 distinct backers are named across the disclosed rounds.

TISSIUM at a glance

Total raised: $161M
Latest round: Series C
Latest round date: August 2021
Headquarters: Boston, Massachusetts
Notable investors: Cathay Health, Cathay Capital, Sofinnova Partners

Frequently asked about TISSIUM funding

How much has TISSIUM raised?: TISSIUM has raised $161M in total disclosed funding across the rounds on record.
Who has invested in TISSIUM?: Cathay Health, Cathay Capital, Sofinnova Partners are named among the investors backing TISSIUM.
What was the latest TISSIUM funding round?: The most recent disclosed round is a Series C, announced in August 2021.
Where is TISSIUM based?: TISSIUM is based in Boston, Massachusetts.
When did TISSIUM last raise?: The last disclosed TISSIUM round closed in August 2021 at Series C.

We update the TISSIUM record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Boston and their backers are listed below.

TISSIUM Funding: $161M Raised, Series C (2021)

TISSIUM funding overview

TISSIUM at a glance

Frequently asked about TISSIUM funding

Companies related to TISSIUM (22)

Browse related funding lists (7)